Previous 10 | Next 10 |
InMode ( NASDAQ: INMD ) rose ~6% pre-market as the medical technologies company said its Q4 revenue will be in the range of $133.2M to $133.4M, and FY22 revenue between $453.9M and $454.1M. The Q4 consensus revenue estimate is $129.45M and FY22 consensus stands at $448.71...
Shares of medical device company InMode (NASDAQ: INMD) gained 59% in the second half of 2022, according to data provided by S&P Global Market Intelligence . This market outperformance came after the stock dropped 70% in the first few months of the year, which is why investors want...
Medical stocks, in general, make good long-term investments; the U.S. national spending on healthcare is expected to keep growing because of an aging population. The level of spending on healthcare as a percentage of the U.S. Gross Domestic Product (GDP) has risen from 5.27% in 1962 to 19.7% ...
If you're picking stocks to buy for your portfolio, you can save some time by looking at ones that Wall Street analysts are already bullish on currently. Analysts spend a lot of time examining a company's financials, and while you shouldn't rely entirely on their findings, they can help steer you...
InMode to Present at the 25th Annual Needham Growth Conference PR Newswire YOKNEAM, Israel , Jan. 3, 2023 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Moshe Mizrahy , Chairm...
Whether you have personal experience with cosmetic surgery or not, this corner of the economy is probably larger than you imagine. Grandview Research recently valued the global cosmetic surgery and procedure market at over $63 billion in 2021 -- and it's growing fast. This figure is expected to g...
It’s no secret that we humans can be a vain bunch. We want to turn back the hands of time as we age. That’s why elective cosmetic surgery has surged past pre-pandemic levels, notes Jimmy Mengel, editor of The Profit Sector. For further details see: Top Picks 2023- InMode INMD
InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s time to look for strong, potential breakout stocks. All as the outlook for the U.S. economy and the overall stock market start to improve. For one, there are multiple signs that the economy is not headed for a signi...
Summary INMD provides a prime opportunity for investors to benefit from the growing demand for non-surgical cosmetic procedures that rely on energy-based devices. INMD manufactures and sells energy based devices used by physicians in these procedures and has between 2019 and 2022 seen a...
Despite trading on U.S. exchanges, MercadoLibre (NASDAQ: MELI) , InMode (NASDAQ: INMD) , and Global-e Online (NASDAQ: GLBE) are headquartered internationally, offering investors access to the global markets. While these three businesses have grown their sales betwe...
News, Short Squeeze, Breakout and More Instantly...
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling PR Newswire IRVINE, Calif. , July 17, 2024 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technolog...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 5.6% to $127.4 on volume of 368,729,821 shares Maxeon Solar Technologies Ltd. (MAXN) rose 14.2% to $0.2407 on volume of 294,399,898 shares Kazia Therapeutics Limited (KZIA) rose 85.6% to $1.24 on volume ...
A look at the top 10 most actives in the United States Kazia Therapeutics Limited (KZIA) rose 106.5% to $1.38 on volume of 71,739,314 shares Renalytix plc (RNLX) rose 41.4% to $0.4269 on volume of 54,892,134 shares Maxeon Solar Technologies Ltd. (MAXN) fell 7.4% to $0.1951 on volume of 45...